In this study, 249 mice identified with SCC tumor growth were treated through a variety of drug regimens. Over the course of 45 days, tumor development was observed and measured. The purpose of this study was to compare the performance of Pymaceuticals' drug of interest, Capomulin, with the other treatment regimens. You have been tasked by the senior scientist team to generate an initial drug regimen comparison and a summary of your findings.